GenMont Biotech Inc (3164) — Working Capital to Net Assets Ratio
GenMont Biotech Inc (3164) has a Working Capital to Net Assets ratio of 26.3% as of March 2026. Working capital of NT$369.77 Million (current assets of NT$578.77 Million minus current liabilities of NT$209.00 Million) is measured against net assets of NT$1.41 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial flexibility index of GenMont Biotech Inc to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
GenMont Biotech Inc Working Capital to Net Assets (2004–2025)
This chart shows how GenMont Biotech Inc's Working Capital to Net Assets ratio has evolved across 22 annual periods from 2004 to 2025. As of March 2026, the ratio stands at 26.3%, reflecting working capital of NT$369.77 Million against net assets of NT$1.41 Billion TWD. See GenMont Biotech Inc (3164) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for GenMont Biotech Inc (2004–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for GenMont Biotech Inc from 2004 to 2025, covering 22 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see GenMont Biotech Inc market cap and net worth.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 29.4% | NT$425.53 Million | NT$1.45 Billion | NT$555.31 Million | NT$129.78 Million | ▲ +2.2 pp |
| 2024 | 27.1% | NT$401.58 Million | NT$1.48 Billion | NT$541.73 Million | NT$140.15 Million | ▲ +5.1 pp |
| 2023 | 22.0% | NT$319.12 Million | NT$1.45 Billion | NT$465.51 Million | NT$146.39 Million | ▼ -2.1 pp |
| 2022 | 24.1% | NT$360.73 Million | NT$1.50 Billion | NT$521.50 Million | NT$160.78 Million | ▼ -4.9 pp |
| 2021 | 29.0% | NT$441.62 Million | NT$1.52 Billion | NT$580.79 Million | NT$139.17 Million | ▼ -4.8 pp |
| 2020 | 33.8% | NT$500.98 Million | NT$1.48 Billion | NT$595.94 Million | NT$94.96 Million | ▼ -7.3 pp |
| 2019 | 41.1% | NT$595.46 Million | NT$1.45 Billion | NT$683.76 Million | NT$88.31 Million | ▼ -24.3 pp |
| 2018 | 65.4% | NT$1.02 Billion | NT$1.56 Billion | NT$1.11 Billion | NT$91.76 Million | ▲ +35.9 pp |
| 2017 | 29.5% | NT$404.13 Million | NT$1.37 Billion | NT$524.05 Million | NT$119.92 Million | ▲ +2.8 pp |
| 2016 | 26.7% | NT$342.02 Million | NT$1.28 Billion | NT$454.27 Million | NT$112.25 Million | ▲ +5.8 pp |
| 2015 | 20.9% | NT$313.43 Million | NT$1.50 Billion | NT$434.53 Million | NT$121.10 Million | ▲ +3.4 pp |
| 2014 | 17.5% | NT$279.57 Million | NT$1.60 Billion | NT$412.15 Million | NT$132.58 Million | ▼ -61.8 pp |
| 2013 | 79.3% | NT$663.86 Million | NT$837.28 Million | NT$1.20 Billion | NT$535.71 Million | ▲ +3.5 pp |
| 2012 | 75.8% | NT$653.00 Million | NT$861.62 Million | NT$1.22 Billion | NT$565.93 Million | ▼ -35.0 pp |
| 2011 | 110.8% | NT$1.00 Billion | NT$904.75 Million | NT$1.11 Billion | NT$102.70 Million | ▲ +0.0 pp |
| 2010 | 110.8% | NT$817.63 Million | NT$737.87 Million | NT$945.20 Million | NT$127.57 Million | ▲ +50.0 pp |
| 2009 | 60.8% | NT$386.65 Million | NT$635.68 Million | NT$474.96 Million | NT$88.30 Million | ▼ -8.5 pp |
| 2008 | 69.3% | NT$422.32 Million | NT$609.60 Million | NT$493.54 Million | NT$71.22 Million | ▲ +0.4 pp |
| 2007 | 68.9% | NT$361.55 Million | NT$524.64 Million | NT$408.44 Million | NT$46.90 Million | ▼ -6.9 pp |
| 2006 | 75.8% | NT$350.18 Million | NT$461.75 Million | NT$407.59 Million | NT$57.41 Million | ▲ +27.4 pp |
| 2005 | 48.4% | NT$140.55 Million | NT$290.14 Million | NT$163.00 Million | NT$22.45 Million | ▲ +2.5 pp |
| 2004 | 45.9% | NT$135.04 Million | NT$294.16 Million | NT$149.86 Million | NT$14.82 Million | — |